cloudfront

Report Detail



OtherGlobal Drug and Gene Delivery Systems Market Size, Status and Forecast 2018-2025

  • RnM2418508
  • |
  • 14 September, 2018
  • |
  • Global
  • |
  • 99 pages
  • |
  • QYResearch
  • |
  • Other

Global Drug and Gene Delivery Systems Market Size, Status and Forecast 2018-2025

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Drug and Gene Delivery Systems Market Size Growth Rate by Type (2013-2025)
      • 1.4.2 Drug Delivery Systems
      • 1.4.3 Gene Delivery Systems
    • 1.5 Market by Application
      • 1.5.1 Global Drug and Gene Delivery Systems Market Share by Application (2013-2025)
      • 1.5.2 Infectious Diseases
      • 1.5.3 Oncology
      • 1.5.4 Ophthalmology
      • 1.5.5 Urology
      • 1.5.6 Diabetes
      • 1.5.7 CNS
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Drug and Gene Delivery Systems Market Size
    • 2.2 Drug and Gene Delivery Systems Growth Trends by Regions
      • 2.2.1 Drug and Gene Delivery Systems Market Size by Regions (2013-2025)
      • 2.2.2 Drug and Gene Delivery Systems Market Share by Regions (2013-2018)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Drug and Gene Delivery Systems Market Size by Manufacturers
      • 3.1.1 Global Drug and Gene Delivery Systems Revenue by Manufacturers (2013-2018)
      • 3.1.2 Global Drug and Gene Delivery Systems Revenue Market Share by Manufacturers (2013-2018)
      • 3.1.3 Global Drug and Gene Delivery Systems Market Concentration Ratio (CR5 and HHI)
    • 3.2 Drug and Gene Delivery Systems Key Players Head office and Area Served
    • 3.3 Key Players Drug and Gene Delivery Systems Product/Solution/Service
    • 3.4 Date of Enter into Drug and Gene Delivery Systems Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Drug and Gene Delivery Systems Market Size by Type (2013-2018)
    • 4.2 Global Drug and Gene Delivery Systems Market Size by Application (2013-2018)

    5 United States

    • 5.1 United States Drug and Gene Delivery Systems Market Size (2013-2018)
    • 5.2 Drug and Gene Delivery Systems Key Players in United States
    • 5.3 United States Drug and Gene Delivery Systems Market Size by Type
    • 5.4 United States Drug and Gene Delivery Systems Market Size by Application

    6 Europe

    • 6.1 Europe Drug and Gene Delivery Systems Market Size (2013-2018)
    • 6.2 Drug and Gene Delivery Systems Key Players in Europe
    • 6.3 Europe Drug and Gene Delivery Systems Market Size by Type
    • 6.4 Europe Drug and Gene Delivery Systems Market Size by Application

    7 China

    • 7.1 China Drug and Gene Delivery Systems Market Size (2013-2018)
    • 7.2 Drug and Gene Delivery Systems Key Players in China
    • 7.3 China Drug and Gene Delivery Systems Market Size by Type
    • 7.4 China Drug and Gene Delivery Systems Market Size by Application

    8 Japan

    • 8.1 Japan Drug and Gene Delivery Systems Market Size (2013-2018)
    • 8.2 Drug and Gene Delivery Systems Key Players in Japan
    • 8.3 Japan Drug and Gene Delivery Systems Market Size by Type
    • 8.4 Japan Drug and Gene Delivery Systems Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Drug and Gene Delivery Systems Market Size (2013-2018)
    • 9.2 Drug and Gene Delivery Systems Key Players in Southeast Asia
    • 9.3 Southeast Asia Drug and Gene Delivery Systems Market Size by Type
    • 9.4 Southeast Asia Drug and Gene Delivery Systems Market Size by Application

    10 India

    • 10.1 India Drug and Gene Delivery Systems Market Size (2013-2018)
    • 10.2 Drug and Gene Delivery Systems Key Players in India
    • 10.3 India Drug and Gene Delivery Systems Market Size by Type
    • 10.4 India Drug and Gene Delivery Systems Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Drug and Gene Delivery Systems Market Size (2013-2018)
    • 11.2 Drug and Gene Delivery Systems Key Players in Central & South America
    • 11.3 Central & South America Drug and Gene Delivery Systems Market Size by Type
    • 11.4 Central & South America Drug and Gene Delivery Systems Market Size by Application

    12 International Players Profiles

    • 12.1 Novartis
      • 12.1.1 Novartis Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Drug and Gene Delivery Systems Introduction
      • 12.1.4 Novartis Revenue in Drug and Gene Delivery Systems Business (2013-2018)
      • 12.1.5 Novartis Recent Development
    • 12.2 Amgen
      • 12.2.1 Amgen Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Drug and Gene Delivery Systems Introduction
      • 12.2.4 Amgen Revenue in Drug and Gene Delivery Systems Business (2013-2018)
      • 12.2.5 Amgen Recent Development
    • 12.3 Oxford BioMedica
      • 12.3.1 Oxford BioMedica Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Drug and Gene Delivery Systems Introduction
      • 12.3.4 Oxford BioMedica Revenue in Drug and Gene Delivery Systems Business (2013-2018)
      • 12.3.5 Oxford BioMedica Recent Development
    • 12.4 SIBIONO
      • 12.4.1 SIBIONO Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Drug and Gene Delivery Systems Introduction
      • 12.4.4 SIBIONO Revenue in Drug and Gene Delivery Systems Business (2013-2018)
      • 12.4.5 SIBIONO Recent Development
    • 12.5 Shanghai Sunway Biotech
      • 12.5.1 Shanghai Sunway Biotech Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Drug and Gene Delivery Systems Introduction
      • 12.5.4 Shanghai Sunway Biotech Revenue in Drug and Gene Delivery Systems Business (2013-2018)
      • 12.5.5 Shanghai Sunway Biotech Recent Development
    • 12.6 Roche
      • 12.6.1 Roche Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Drug and Gene Delivery Systems Introduction
      • 12.6.4 Roche Revenue in Drug and Gene Delivery Systems Business (2013-2018)
      • 12.6.5 Roche Recent Development
    • 12.7 Pfizer
      • 12.7.1 Pfizer Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Drug and Gene Delivery Systems Introduction
      • 12.7.4 Pfizer Revenue in Drug and Gene Delivery Systems Business (2013-2018)
      • 12.7.5 Pfizer Recent Development
    • 12.8 Bayer
      • 12.8.1 Bayer Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Drug and Gene Delivery Systems Introduction
      • 12.8.4 Bayer Revenue in Drug and Gene Delivery Systems Business (2013-2018)
      • 12.8.5 Bayer Recent Development
    • 12.9 Johnson & Johnson
      • 12.9.1 Johnson & Johnson Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Drug and Gene Delivery Systems Introduction
      • 12.9.4 Johnson & Johnson Revenue in Drug and Gene Delivery Systems Business (2013-2018)
      • 12.9.5 Johnson & Johnson Recent Development
    • 12.10 Becton Dickinson
      • 12.10.1 Becton Dickinson Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Drug and Gene Delivery Systems Introduction
      • 12.10.4 Becton Dickinson Revenue in Drug and Gene Delivery Systems Business (2013-2018)
      • 12.10.5 Becton Dickinson Recent Development
    • 12.11 AstraZeneca
    • 12.12 Baxter
    • 12.13 HSCI
    • 12.14 Epeius Biotechnologies

    13 Market Forecast 2018-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2018-2025)
    • 13.10 Market Size Forecast by Application (2018-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      This report focuses on the global Drug and Gene Delivery Systems status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Drug and Gene Delivery Systems development in United States, Europe and China.

      Drug delivery includes formulations, technologies, methods, and systems used for transferring an active pharmaceutical ingredient into the body as desired, in order to safely accomplish its therapeutic effect. Gene delivery is a procedure employed to introduce foreign DNA into host cells.
      In 2017, the global Drug and Gene Delivery Systems market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

      The key players covered in this study
      Novartis
      Amgen
      Oxford BioMedica
      SIBIONO
      Shanghai Sunway Biotech
      Roche
      Pfizer
      Bayer
      Johnson & Johnson
      Becton Dickinson
      AstraZeneca
      Baxter
      HSCI
      Epeius Biotechnologies

      Market segment by Type, the product can be split into
      Drug Delivery Systems
      Gene Delivery Systems

      Market segment by Application, split into
      Infectious Diseases
      Oncology
      Ophthalmology
      Urology
      Diabetes
      CNS

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Drug and Gene Delivery Systems status, future forecast, growth opportunity, key market and key players.
      To present the Drug and Gene Delivery Systems development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Drug and Gene Delivery Systems are as follows:
      History Year: 2013-2017
      Base Year: 2017
      Estimated Year: 2018
      Forecast Year 2018 to 2025
      For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.




      Summary:
      Get latest Market Research Reports on Drug and Gene Delivery Systems . Industry analysis & Market Report on Drug and Gene Delivery Systems is a syndicated market report, published as Global Drug and Gene Delivery Systems Market Size, Status and Forecast 2018-2025. It is complete Research Study and Industry Analysis of Drug and Gene Delivery Systems market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $7,800.00
      2,618.85
      5,237.70
      3,588.78
      7,177.56
      472,446.00
      944,892.00
      258,622.26
      517,244.52
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report